Paul Weiss-Led AbbVie Inks Up To $212M Deal For Landos Bio

By Al Barbarino · March 25, 2024, 4:51 PM EDT

AbbVie Inc., represented by Paul Weiss Rifkind Wharton & Garrison LLP, said Monday it will pay up to $212.5 million for Cooley LLP-led Landos Biopharma Inc., a clinical-stage biopharmaceutical company developing treatments for...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login